93 related articles for article (PubMed ID: 23505293)
21. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
[TBL] [Abstract][Full Text] [Related]
22. HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT.
Noh JH; Bae HJ; Eun JW; Shen Q; Park SJ; Kim HS; Nam B; Shin WC; Lee EK; Lee K; Jang JJ; Park WS; Lee JY; Nam SW
Cancer Res; 2014 Mar; 74(6):1728-38. PubMed ID: 24448241
[TBL] [Abstract][Full Text] [Related]
23. Trans-species learning of cellular signaling systems with bimodal deep belief networks.
Chen L; Cai C; Chen V; Lu X
Bioinformatics; 2015 Sep; 31(18):3008-15. PubMed ID: 25995230
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of cMet tyrosine residues in murine ascitic hepatic cancer cell lines with different lymph node metastatic potentials.
Li Y; Huang X; Zhang Q; Ma K
Mol Med Rep; 2013 Aug; 8(2):655-61. PubMed ID: 23778885
[TBL] [Abstract][Full Text] [Related]
25. [Cross-talk between PI3K/Akt and MEK/ERK pathways regulates human hepatocellular carcinoma cell cycle progression under endoplasmic reticulum stress].
Yan DM; Dai RY; Duan CY; Chen SK; Liu YP; Chen CN; Li H
Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):909-14. PubMed ID: 21205476
[TBL] [Abstract][Full Text] [Related]
26. Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
Han P; Li H; Jiang X; Zhai B; Tan G; Zhao D; Qiao H; Liu B; Jiang H; Sun X
Mol Oncol; 2017 Mar; 11(3):320-334. PubMed ID: 28164434
[TBL] [Abstract][Full Text] [Related]
27. Reverse engineering of logic-based differential equation models using a mixed-integer dynamic optimization approach.
Henriques D; Rocha M; Saez-Rodriguez J; Banga JR
Bioinformatics; 2015 Sep; 31(18):2999-3007. PubMed ID: 26002881
[TBL] [Abstract][Full Text] [Related]
28. Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness.
Wan S; Meyer AS; Weiler SME; Rupp C; Tóth M; Sticht C; Singer S; Thomann S; Roessler S; Schorpp-Kistner M; Schmitt J; Gretz N; Angel P; Tschaharganeh DF; Marquardt J; Schirmacher P; Pinna F; Breuhahn K
Hepatology; 2018 May; 67(5):1842-1856. PubMed ID: 29152770
[TBL] [Abstract][Full Text] [Related]
29. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
Liu Y; Zhao Y; Guo L
Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src/PI3K/Akt pathway.
Liu H; Xu J; Zhou L; Yun X; Chen L; Wang S; Sun L; Wen Y; Gu J
Cancer Res; 2011 Dec; 71(24):7547-57. PubMed ID: 21994334
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism.
Berasain C; Nicou A; Garcia-Irigoyen O; Latasa MU; Urtasun R; Elizalde M; Salis F; Perugorría MJ; Prieto J; Recio JA; Corrales FJ; Avila MA
Dig Dis; 2012; 30(5):524-31. PubMed ID: 23108309
[TBL] [Abstract][Full Text] [Related]
32. Sp1 is involved in regulation of cystathionine γ-lyase gene expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell lines.
Yin P; Zhao C; Li Z; Mei C; Yao W; Liu Y; Li N; Qi J; Wang L; Shi Y; Qiu S; Fan J; Zha X
Cell Signal; 2012 Jun; 24(6):1229-40. PubMed ID: 22360859
[TBL] [Abstract][Full Text] [Related]
33. Detecting subnetwork-level dynamic correlations.
Yan Y; Qiu S; Jin Z; Gong S; Bai Y; Lu J; Yu T
Bioinformatics; 2017 Jan; 33(2):256-265. PubMed ID: 27667792
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
[TBL] [Abstract][Full Text] [Related]
35. Nickel and copper ion-induced stress signaling in human hepatoma cells: analysis of phosphoinositide 3'-kinase/Akt signaling.
Eckers A; Reimann K; Klotz LO
Biometals; 2009 Apr; 22(2):307-16. PubMed ID: 18925359
[TBL] [Abstract][Full Text] [Related]
36. Understanding the limits of animal models as predictors of human biology: lessons learned from the sbv IMPROVER Species Translation Challenge.
Rhrissorrakrai K; Belcastro V; Bilal E; Norel R; Poussin C; Mathis C; Dulize RH; Ivanov NV; Alexopoulos L; Rice JJ; Peitsch MC; Stolovitzky G; Meyer P; Hoeng J
Bioinformatics; 2015 Feb; 31(4):471-83. PubMed ID: 25236459
[TBL] [Abstract][Full Text] [Related]
37. Inter-species prediction of protein phosphorylation in the sbv IMPROVER species translation challenge.
Biehl M; Sadowski P; Bhanot G; Bilal E; Dayarian A; Meyer P; Norel R; Rhrissorrakrai K; Zeller MD; Hormoz S
Bioinformatics; 2015 Feb; 31(4):453-61. PubMed ID: 24994890
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling.
Bose S; Sakhuja P; Bezawada L; Agarwal AK; Kazim SN; Khan LA; Sarin SK; Ramakrishna G
J Gastroenterol Hepatol; 2011 Jan; 26(1):135-44. PubMed ID: 21175807
[TBL] [Abstract][Full Text] [Related]
39. Reactive oxygen species-mediated activation of the Src-epidermal growth factor receptor-Akt signaling cascade prevents bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Hou J; Cui A; Song P; Hua H; Luo T; Jiang Y
Mol Med Rep; 2015 Jan; 11(1):712-8. PubMed ID: 25338626
[TBL] [Abstract][Full Text] [Related]
40. [Role of PI3K/AKT signaling pathway in clonogenicity and tumorigenicity of CD90+ stem-like cells of the hepatocellular carcinoma cell line MHCC-97H].
Peng YC; Peng NF; Xie ZB; Lu SD; Zhong JH; Pang YB; Zhu SL; You XM; Li LQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):285-90. PubMed ID: 27470628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
